{"id":"W4391392140","doi":"10.1002/nau.25399","title":"Safety and efficacy of an α<sub>1</sub>‐blocker plus mirabegron compared with an α<sub>1</sub>‐blocker plus antimuscarinic in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia and overactive bladder: A systematic review and network meta‐analysis","year":2024,"lang":"en","type":"review","venue":"Neurourology and Urodynamics","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Astellas Foundation for Research on Metabolic Disorders; Astellas Pharma","keywords":"Medicine; Overactive bladder; Mirabegron; Lower urinary tract symptoms; International Prostate Symptom Score; Urology; Placebo; Benign prostatic hyperplasia (BPH); Adverse effect; Urinary retention; Internal medicine; Prostate","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001269897,0.001295026,0.00842271,0.0009114035,0.0002171997,0.000109921,0.000247377,0.0005163049,0.00001100885],"category_scores_gemma":[0.00008029143,0.0008771949,0.0004065941,0.001523158,0.0005721952,0.0003237351,0.0003440536,0.002066816,0.000003366575],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001137218,"about_ca_system_score_gemma":0.0007033761,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003206483,"about_ca_topic_score_gemma":0.0002127244,"domain_scores_codex":[0.9930764,0.001918609,0.001579679,0.001957065,0.000557595,0.0009106959],"domain_scores_gemma":[0.9962817,0.001128355,0.0006488154,0.001053411,0.0001812562,0.0007064957],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.01317822,0.002332528,0.001044097,0.8513901,0.106921,0.01064527,0.001875396,0.0007368188,0.00002363475,0.00008431481,0.00005789672,0.01171069],"study_design_scores_gemma":[0.008565102,0.033078,0.01203629,0.04803591,0.8348756,0.03668237,0.0002148984,0.02298689,0.000002679657,0.00005417716,0.001030227,0.002437851],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.261553,0.7315204,0.00002052756,0.0001961301,0.0000349488,0.006293982,0.0002390691,0.00005541573,0.0000864538],"genre_scores_gemma":[0.1509051,0.8474945,0.0001272683,0.0003611625,0.00004326972,0.0003502287,0.0004879558,0.0001931314,0.00003737308],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8033541,"threshold_uncertainty_score":0.9999802,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02151678448308692,"score_gpt":0.308127459509782,"score_spread":0.2866106750266951,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}